Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2023

May 23, 2023

33298_dirs_2023-05-23_fb6581d5-2c6f-478c-8f71-7e69c74c0f1f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-05-23

Reporting Person: Galluppi Stefan (Chief Innovation Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-23 Common Stock, par value $0.01 P 10000 $2.17 Acquired 17841 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.01 1644800 Indirect